NantHealth (NASDAQ:NH) Trading Up 17.5%

Shares of NantHealth Inc (NASDAQ:NH) were up 17.5% on Wednesday . The company traded as high as $2.18 and last traded at $2.01, approximately 1,180,694 shares were traded during mid-day trading. An increase of 5% from the average daily volume of 1,125,597 shares. The stock had previously closed at $1.71.

A number of equities research analysts have weighed in on NH shares. ValuEngine upgraded NantHealth from a “sell” rating to a “hold” rating in a report on Tuesday, February 4th. Zacks Investment Research downgraded NantHealth from a “buy” rating to a “hold” rating in a report on Thursday, December 19th.

The firm has a market capitalization of $222.35 million, a P/E ratio of -2.21 and a beta of 1.32. The stock has a fifty day simple moving average of $1.48 and a two-hundred day simple moving average of $0.95.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in NH. Tower Research Capital LLC TRC increased its holdings in shares of NantHealth by 778.8% during the third quarter. Tower Research Capital LLC TRC now owns 45,988 shares of the company’s stock valued at $33,000 after acquiring an additional 40,755 shares in the last quarter. Paragon Wealth Strategies LLC bought a new stake in shares of NantHealth during the fourth quarter valued at approximately $38,000. Renaissance Technologies LLC increased its holdings in shares of NantHealth by 28.1% during the fourth quarter. Renaissance Technologies LLC now owns 513,728 shares of the company’s stock valued at $529,000 after acquiring an additional 112,605 shares in the last quarter. Jacobs Levy Equity Management Inc. increased its holdings in shares of NantHealth by 74.4% during the fourth quarter. Jacobs Levy Equity Management Inc. now owns 88,640 shares of the company’s stock valued at $91,000 after acquiring an additional 37,812 shares in the last quarter. Finally, Bank of America Corp DE bought a new stake in shares of NantHealth during the fourth quarter valued at approximately $31,000. Hedge funds and other institutional investors own 2.83% of the company’s stock.

About NantHealth (NASDAQ:NH)

NantHealth, Inc, together with its subsidiaries, operates as a healthcare technology company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care. It develops NantHealth solutions, including molecular profiling solutions, software, and hardware systems infrastructure, which integrates patient data management, bioinformatics, and molecular medicine to enable value-based care and evidence-based clinical practice.

Featured Article: What are different types of coverage ratios?

Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.